台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    66.6
  • 漲跌
    ▼0.9
  • 漲幅
    -1.33%
  • 成交量
    208
  • 產業
    上櫃 生技醫療類股
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-中國信託-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/0355606570758085May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

中國信託-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2700.00273.9073.60-2573-0.35%
2025/03/26276.0000.0074.7025770.35%
2025/03/2400.00472.0872.20-4593-0.67%
2025/03/20473.5500.0073.1045950.67%
2025/03/1900.00275.4072.60-2598-0.33%
2025/03/18175.70376.6075.50-2602-0.33%
2025/03/1700.00377.8077.50-3616-0.49%
2025/03/1400.00177.0077.70-1617-0.16%
2025/03/1300.00377.7781.00-3603-0.50%
2025/03/1200.00180.5077.50-1585-0.17%
2025/03/11379.1000.0081.5035570.54%
2025/03/10471.801.374.8476.802.75180.52%
2025/03/07170.1000.0069.9014960.20%
2025/03/0600.00568.1067.60-5483-1.03%
2025/03/0300.00169.2069.60-1483-0.21%
2025/02/21569.54170.0067.8045080.79%
2025/02/2000.00165.3071.00-1497-0.20%
2025/02/1700.00162.5062.20-1521-0.19%
2025/02/1300.00162.4062.80-1574-0.17%
2025/02/12563.2000.0061.9055850.85%
2025/02/0600.00260.7060.60-2600-0.33%
2025/01/1400.00260.8062.90-2621-0.32%
2025/01/1300.00164.2062.80-1627-0.16%
2025/01/0800.00262.5062.00-2618-0.32%
2025/01/07163.3000.0062.8016220.16%
2024/12/260.167.202.267.5566.60-2.2692-0.31%
2024/12/252.373.2400.0074.002.36830.33%
2024/12/2000.00161.1060.40-1684-0.15%
2024/12/19165.00165.7062.7006950.00%
2024/12/1100.00355.0054.90-3666-0.45%
2024/12/10161.7000.0060.9016480.15%
2024/12/0900.00962.6062.00-9646-1.39%
2024/12/03367.5000.0067.8036620.45%
2024/11/27266.2500.0066.5026770.30%
2024/11/26168.6000.0068.6016810.15%
2024/11/25171.9000.0071.9016810.15%
2024/11/2200.00170.0073.00-1672-0.15%
2024/11/19167.10167.8067.4006670.00%
2024/11/18166.20266.8567.00-1676-0.15%
2024/11/14167.0000.0069.0016700.15%
2024/11/13263.5500.0064.0026520.31%
2024/11/12268.6000.0070.0026320.32%
2024/11/1100.00170.1070.10-1606-0.16%
2024/11/07588.2000.0086.1056200.81%
2024/11/0600.00285.2085.20-2634-0.32%
2024/11/05284.8000.0084.9026360.31%
2024/10/30195.0000.0093.8016700.15%
2024/10/28294.6000.0095.5026880.29%
2024/10/2500.001100.50100.00-1687-0.15%
2024/10/232107.0000.00104.0027100.28%
2024/10/222105.5000.00107.0027260.28%
2024/10/211103.5000.00105.5017360.14%
2024/10/1800.005113.00110.00-5768-0.65%
2024/10/152119.2500.00117.0028110.25%
2024/10/1400.000.3115.50121.00-0.3817-0.04%
2024/10/1100.001119.00114.50-1824-0.12%
2024/10/072115.7500.00116.5028300.24%
2024/10/0100.001.297.2097.20-1.2787-0.15%
2024/09/251155.5000.00147.5017840.13%
2024/09/194172.500.9176.00177.003.27850.40%
2024/09/1800.001178.00175.00-1779-0.13%
2024/09/161176.000.2179.67175.500.97800.11%
2024/08/213218.0000.00225.0038020.37%
2024/08/2000.000.9217.81216.00-0.9806-0.11%
2024/08/1900.001198.00201.50-1820-0.12%
2024/08/061176.0000.00171.0017770.13%
2024/08/0500.001179.00180.00-1768-0.13%
2024/07/2900.006146.58141.50-6708-0.85%
2024/07/266156.583152.50148.0037000.43%
2024/07/1900.001187.00182.00-1650-0.15%
2024/07/181194.0000.00196.5016110.16%
2024/07/161172.0000.00174.5015660.18%
2024/07/1500.001160.00164.50-1554-0.18%
2024/07/121161.501157.50162.0005440.00%
2024/07/111146.5000.00149.0015310.19%
2024/07/013130.5000.00137.5034350.69%
2024/06/2800.002125.00130.00-2413-0.48%
2024/06/191104.0000.00101.5013740.27%
2024/06/181105.5000.00104.5013640.27%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音
 
 
05小時40